Cholinesterase inhibitors and cardiovascular disease: a survey of old age psychiatrists' practice.
Malone
Darren M
DM
Clinical Division of Psychiatry, Department of Health Sciences, Leicester General Hospital, Leicester, UK. dm91@le.ac.uk
Lindesay
James
J
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000503:physiopathology; D002800:Cholinesterase Inhibitors / Q000009:adverse effects*; D015897:Comorbidity; D004562:Electrocardiography; D004739:England / Q000453:epidemiology; D005852:Geriatric Psychiatry / Q000706:statistics & numerical data*; D019538:Health Care Surveys; D007722:Health Knowledge, Attitudes, Practice; D006297:Health Services Accessibility; D006299:Health Services for the Aged / Q000706:statistics & numerical data*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011795:Surveys and Questionnaires
D002800:Cholinesterase Inhibitors